What is the DongKook Pharmaceutical Co., Ltd. stock price forecast?

DongKook Pharmaceutical Co., Ltd. is currently trading at ₩20,500. View real-time AI analysis on Alpha Lenz.

What is DongKook Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for DongKook Pharmaceutical Co., Ltd. on Alpha Lenz.

What is DongKook Pharmaceutical Co., Ltd.'s P/E ratio?

DongKook Pharmaceutical Co., Ltd.'s P/E ratio is 13.8.

DongKook Pharmaceutical Co., Ltd.

KRX · 086450

₩20,500-600(-2.84%)Market closed

Ask about DongKook Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“DongKook Pharmaceutical Co., Ltd. trades at a P/E of 13.8 (undervalued) with solid ROE of 10.4%. 3Y revenue CAGR of 11.9% highlights clear growth momentum.”

Ask for details →

Company Overview

CEO송준호

Websitehttps://www.dkpharm.co.kr

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩927,223,610,000Market Cap

₩926,883,701,820Revenue

45.23MShares Out

0Employees

Margins

54.12%Gross

14.16%EBITDA

10.42%Operating

9.99%Pre-Tax

7.98%Net

Valuation

13.79P/E

1.37P/B

0.98EV/Sales

7.85EV/EBITDA

39.98P/FCF

Growth (CAGR)

11.89%Rev 3Yr

10.64%Rev 5Yr

9.30%Op Inc 3Yr

2.61%Op Inc 5Yr

10.53%Net Inc 3Yr

5.02%Net Inc 5Yr

Returns

7.33%ROA

10.42%ROE

9.39%ROIC

Financial Health

₩56,178,706,280Cash & Cash Equivalents

₩242,979,055,590Net Debt

39.17%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“DongKook Pharmaceutical Co., Ltd. trades at a P/E of 13.8 (undervalued) with solid ROE of 10.4%. 3Y revenue CAGR of 11.9% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

DongKook Pharmaceutical Co., Ltd. (ticker: 086450) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $927.2B.

The current price is ₩20,500 with a P/E ratio of 13.79x and P/B of 1.37x.

ROE is 10.42% and operating margin is 10.42%. Annual revenue is $926.9B.